P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Medical Labs & Research	22.78B	17.85B	14.84B	17.96B
Medical Labs & Research Growth	27.66%	20.24%	-17.34%	-
Total	22.78B	17.85B	14.84B	17.96B
Total Growth	27.66%	20.24%	-17.34%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
South Korea	22.78B	17.85B	14.84B	17.96B
South Korea Growth	27.66%	20.24%	-17.34%	-
Total	22.78B	17.85B	14.84B	17.96B
Total Growth	27.66%	20.24%	-17.34%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error